Skip to main content

US adult smokers’ perceived relative risk on ENDS and its effects on their transitions between cigarettes and ENDS



Perceived risk reduction motivates smokers to switch to electronic nicotine delivery systems (ENDS). This research examines US smokers’ relative risk perceptions and their prospective association with various behavioral stages of switching to ENDS.


Data from the nationally representative, longitudinal Population Assessment of Tobacco and Health (PATH) Adult survey, Waves 1 (2014) through 5 (2019), were analyzed. We assessed the association between the perceived risk of ENDS relative to cigarettes (“less harmful” vs. “equally harmful” or “more harmful”) and 1) adoption of ENDS (among never-ENDS-using smokers), 2) complete switching to ENDS (i.e., stopping smoking, among ever-ENDS-using smokers), and 3) avoiding reversion to smoking (among smokers who had switched to ENDS), at the next wave.


The proportion of US smokers perceiving ENDS as less harmful than cigarettes continually decreased, reaching 17.4% in Wave 5 (2019). Current smokers with such belief were more likely to adopt ENDS (aOR 1.31; 95% CI 1.15–1.50) and switch completely to ENDS (aOR 2.24; 95% CI 1.89–2.65) in the subsequent wave. Among smokers who had switched within the past year, such beliefs predicted avoidance of resumption of smoking in the next wave (aOR 0.55; 95% CI 0.33–0.93).


Smokers’ beliefs about the relative risk of ENDS compared to cigarettes had a strong and consistent association with transitions between smoking and ENDS use. Addressing the growing misperception about ENDS has the potential to contribute to public health by encouraging smokers’ switching to ENDS.

Peer Review reports


Combustible cigarette smoking continues to be the leading cause of preventable morbidity and mortality in the US, [1] with 34.1 million US adults smoking in 2019 [2]. There is a scientific consensus that the toxicity of cigarettes largely comes from the products of combustion [3]. Accordingly, electronic nicotine delivery systems (ENDS), which deliver nicotine without combustion, have been estimated to have a considerably lower risk profile compared to cigarettes [1, 4,5,6]. This concept of the continuum of risk (that some nicotine-delivering products are less harmful than the others), while broadly acknowledged by the literature, regulatory agencies, and health bodies around the world, [4, 5, 7,8,9,10,11,12] has not been well-communicated to smokers or the general population. In fact, several studies suggest that the proportion of US adults who perceive ENDS as at least as harmful as cigarettes continues to increase, [13, 14] reflecting the exacerbation of this misunderstanding among the general public. We refer to such beliefs as misperceptions, consistent with the literature on the topic [4, 14, 15].

As suggested by the health belief model [16] and the theory of planned behavior, [17] perceived risks and benefits are major drivers of health behaviors. Current and former smokers who have used ENDS often indicate that the one of their most important reasons for using ENDS is because they perceive ENDS as posing lower health risks compared to cigarettes [18]. Conversely, misperceiving the relative risk of ENDS was one of the reasons given for not being willing to try ENDS and for choosing not to switch completely to ENDS [19]. Collectively, these results suggest that the misperception of ENDS may deter smokers from harm reduction behaviors such as adopting and switching to ENDS, [20, 21] and may lead to increased harm by driving exclusive ENDS users back to cigarette smoking [21].

For ENDS use to have its intended harm reduction benefit on smokers who would not otherwise quit, they must start using ENDS (which we refer to as “adoption”), stop smoking and switch instead to ENDS use (“switching”), and maintain the switched status and avoid reverting to smoking (“reversion”). Although dual use may still be beneficial if accompanied by a substantial reduction in cigarette consumption, [22] switching completely has the biggest potential benefit. The first year after switching was considered as a particularly important period of risk for reversion, as this is the highest risk period for relapse in smoking cessation [23, 24] and ENDS use [25, 26]. Using the Population Assessment of Tobacco and Health (PATH) data, the current research aims to examine the association of adult smokers’ relative risk perception of ENDS on future smoking/vaping behaviors. The analyses examine the prospective relationship between risk perceptions and three aspects or stages of switching to ENDS: (1) initial adoption of ENDS; (2) switching away from smoking to ENDS; and (3) reverting to smoking (vs. maintaining switching).



Data were from the PATH Adult study, an ongoing prospective, nationally representative cohort study of US adults’ tobacco use. The study recruitment was based on a multi-level probability sampling design with oversampling of several underrepresented subgroups. The complex survey design with population and replicate weights adjusts for the study design as well as survey non-response, which allows for generalizable estimation of tobacco use behaviors of US civilian, non-institutionalized adults. Details of the PATH study methodology have been published elsewhere [27]. The analysis combined PATH data from Wave 1 (collected between Sep 2013 – Dec 2014), Wave 2 (Oct 2014 – Oct 2015), Wave 3 (Oct 2015 – Oct 2016), Wave 4 (Dec 2016 – Jan 2018), and Wave 5 (Dec 2018 – Nov 2019) of PATH. The longitudinal data allow assessment of the temporal relationship; i.e., how risk perception at one wave (referred to as Wave t) is associated with the behavior in the next wave (Wave t + 1).

Participants were classified based on their smoking and vaping status at each wave. Based on the well-established definition used by the PATH study as well as other national surveys, [27,28,29] participants were defined as current established smokers if they had smoked 100 or more cigarettes in their lifetime and stated that they currently smoked “some days” or “every day.” Current established smokers were further stratified by lifetime history of ENDS use. Never-users of ENDS were the sample for analyses of ENDS adoption. For analyses of switching, the denominator was smokers who had used ENDS, whether they were currently using them or not. This encompasses all smokers who have completed the initial step towards switching and may achieve complete switching in the following wave, but does not specifically limit to those who were dual users at the time of the survey, as this would oversample persistent dual users and would fail to capture those who adopted ENDS and switched between survey waves. For analyses of reversion to smoking, the sample included former smokers who reported switching to exclusive ENDS use (i.e., using ENDS and no longer smoking).

Participants could have been included in the analysis more than once as long as they met the eligibility criteria for each particular analysis at the relevant wave. The generalized estimating equation (GEE) analysis took account of multiple observations per person, as well as accounting for missing observations at particular waves.

Initial univariate analyses used 9,321 observations from 4,842 never-ENDS-using smokers for the analysis of ENDS adoption; 22,920 observations from 9,438 ever-ENDS-using smokers for the analysis of switching to ENDS; 1,848 observations from 1,151 switchers for the analysis of reversion back to cigarettes. The number of observations used for multivariable modeling may differ due to occasional missing covariates and is shown in footnotes to the corresponding tables.


Predictor: relative risk perception

Relative risk perception was assessed at each wave with a single question. Participants were asked, “Is using e-cigarettes less harmful, about the same, or more harmful than smoking cigarettes?” with participants choosing one of three options, “less harmful,” “about the same,” or “more harmful.” Consistent with previous analyses of risk perception in the PATH data, [14, 30, 31] responses were dichotomized into “less harmful than cigarettes (correct perception)” vs. “equally or more harmful than cigarettes (misperception).” Sensitivity analyses were conducted using all three levels of relative risk perception (Supplementary Table 1). No significant differences between perceiving ENDS to be “equally harmful” and “more harmful” than cigarettes were found, though the effects reported below were seen particularly for the contrast between “less harmful” and “more harmful.” At Wave 1, the risk perception item was asked only of those who had seen or heard of ENDS.

Outcomes: adoption, switching, and reversion

Consistent with the definition of current cigarette smokers/ENDS users described above, study outcomes were also based on using cigarettes or ENDS “every day” or “some day,” compared to using “not at all.” Three outcomes were examined: adoption of ENDS (using ENDS, among previous-wave smokers who have never used ENDS), switching away from smoking with ENDS (no longer smoking but using ENDS, among previous-wave smokers who had used ENDS), and reverting to smoking (return to smoking, whether along with ENDS or not, among “switchers”; i.e., previous-wave former smokers who were currently using ENDS. In each case, the outcome at Wave t + 1 was modeled prospectively as a function of risk perception at wave t. For example, among smokers who at Wave t had never used ENDS, adoption of ENDS at Wave t + 1 was modeled with Wave t risk perceptions.


Six covariates were included to account for sociodemographic characteristics: race/ethnicity, age, sex, educational attainment, marital status, and household income (see Tables 1, 2, and 3). Covariates were time-varying, changing to reflect participants’ wave-to-wave changes in sociodemographic factors such as age and income level. Marital status was not asked in the Wave 1 survey; therefore, marital status at Wave 1 was extrapolated from Wave 2.

Sample descriptors

To characterize the sample, smoking status (daily/nondaily), average cigarettes per day (CPD), years of regular smoking, and time-to-first-cigarette (a measure of cigarette dependence [32]) were described for current smokers. For switchers, average CPD when smoking, years of regular smoking before quitting, and the duration of quitting were described (Supplemental Table 2). We did not include these as covariates in the model, as they could be affected by risk perceptions, leading to overcontrol in the models.


The relationship between the risk perception (at Wave t) and the outcome (at Wave t + 1) was assessed using weighted GEE models [33]. Each observation was weighted using survey weights at Wave t + 1. Weights could vary over waves, and took account of non-response at each wave, as well as entry of new participants into the PATH adult cohort. GEE models estimated the population-averaged effects of risk perception while accounting for the repeated-measure design and resultant within-participant interdependence in multi-wave data from the PATH study, using the SAS Macro developed by the PATH study team (see Kasza et al. [34]). Variances were estimated using Fay’s balanced repeated replication method with an adjustment factor of 0.3 [33]. An exchangeable correlation structure was used, based on the quasi-likelihood information criterion (QIC) statistics [35]. Multivariable models were adjusted for time (using the wave number), and the covariates described above. Based on the temporal patterns observed in Figs. 2, 3 and 4 and improvement in model fit, quadratic terms were included in the adoption and switching analyses; the fit indices for the reversion models did not indicate a quadratic term was needed in those models. Inclusion of the quadratic term did not change the association between risk perceptions and subsequent outcomes (inclusion of the quadratic term reduced the aOR for risk perceptions by no more than 0.05). Follow-up subgroup analyses were conducted for the outcome of reversion among switchers, to examine reversion in the first year after switching.


Figure 1 shows the trend of participants’ relative risk perception over Waves. The perceived risk of ENDS compared to smoking increased over time among current established smokers, with increasing proportions of smokers perceiving ENDS to be equally or more harmful than cigarettes (red line). In the subsamples of this study (greyscale lines), across Waves, Switchers were least likely to report perceiving ENDS as harmful as smoking, while smokers who had never used ENDS were most likely to report such perceptions. However, the proportion perceiving ENDS as at least as harmful as smoking increased over time in all groups, even among Switchers. Figures 2, 3, and 4 depict the proportion of adoption, switching, and reversion of the participants at the following wave by the level of risk perception, respectively, and the standard errors of the proportions.

Fig. 1
figure 1

Percent of smokers perceiving ENDS to be at least as harmful as cigarettes. ENDS: electronic nicotine delivery system. Note: Statistics indicate weighted percentages, calculated cross-sectionally at each wave

Fig. 2
figure 2

Percent of never-ENDS-using smokers adopting ENDS, by previous-wave relative risk perceptions. ENDS: electronic nicotine delivery system. Note: Weighted percentages and standard errors using ENDS at Wave t + 1, stratified by the relative risk perception on ENDS at Wave t, calculated cross-sectionally at each wave. Individual PATH participants could contribute to more than one time-point

Fig. 3
figure 3

Percent of ever-ENDS-using smokers who switched from smoking to ENDS, by previous-wave relative risk perceptions. ENDS: electronic nicotine delivery system. Note: Weighted percentages and standard errors who switched away from smoking at Wave t + 1, stratified by the relative risk perception on ENDS at Wave t, calculated cross-sectionally at each wave. Individual PATH participants could contribute to more than one time-point

Fig. 4
figure 4

Percent of smokers who switched that reverted back to smoking, by previous-wave relative risk perceptions. ENDS: electronic nicotine delivery system; Switcher: former established smokers who are currently using ENDS. Note: Weighted percentages and standard errors of participants who reverted to smoking at Wave t + 1, stratified by the relative risk perception on ENDS at Wave t, calculated cross-sectionally at each wave. Individual PATH participants could contribute to more than one time-point

For each of the following analyses Supplemental Table 3 summarizes the sociodemographic characteristics of the sample and their outcomes in the following wave.

Smokers’ adoption of ENDS

As seen in Fig. 2, the likelihood of ENDS adoption varied significantly as a quadratic function of time: the odds of adoption decreased roughly until Wave 4, then increased between Waves 4 and 5. In univariate analysis, smokers who perceived ENDS as less harmful than cigarettes had 68% greater odds (OR = 1.68, 95% CI: 1.35–2.09) of reporting later adoption of ENDS (Table 1). After adjusting for these sociodemographic factors in Multivariable analyses, perceiving ENDS as less harmful than cigarettes was associated with 35% (aOR = 1.35, 95% CI: 1.14–1.50) increased odds of later adoption of ENDS.

Table 1 Adoption of ENDS among never-ENDS-using smokers: risk perceptions and sociodemographic characteristics

Smokers’ switching to ENDS

As with the adoption of ENDS, the data showed a sharp rise in rates of switching between Waves 4 and 5 (Fig. 3). Univariate analyses showed that smokers who perceived ENDS as less harmful than cigarettes were more likely to subsequently switch to ENDS; their odds of switching in the following year were 134% higher (OR = 2.34, 95% CI: 2.00–2.76) than those of participants who thought ENDS were at least as harmful as cigarettes (Table 2). The association of switching with risk perceptions remained strong (a 127% increase in odds of switching, aOR = 2.27, 95% CI: 1.92–2.68) even after adjusting for demographic factors and the PATH wave.

Table 2 Switching among ever-ENDS-using smokers: risk perceptions and sociodemographic characteristics

Switchers’ reversion to smoking

In univariate analyses, participants who believed that ENDS were equally or more harmful than smoking had 37% higher odds (OR = 1.37, 95% CI: 0.98–1.93) of subsequently resuming cigarette smoking, though the association was not statistically significant (P = 0.0672). Controlling for these demographic factors did not materially change the findings (Table 3).

Table 3 Reversion to smoking among switchers: risk perceptions and sociodemographic characteristics

To further explore the relationship between risk perceptions and reversion, a further analysis stratified switchers according to the length of smoking abstinence (switching), as those with shorter switching history were expected to be more susceptible to reversion. Although the interaction between switch duration (less than a year vs. a year or more) and risk perceptions was not statistically significant (P = 0.5229), the literature on smoking cessation strongly suggests that the first year of switching would be a critical period in reversion to smoking, [23,24,25,26] suggesting the utility of examining the effect among those with shorter switch periods. Those who had switched for less than a year had significantly increased odds of reversion (by 78%, aOR = 1.78, 95% CI: 1.04–3.06) if they believed ENDS use was at least as harmful as smoking (Table 4). Though the effect was in the same direction for the participants who had switched for a year or more, it was smaller and not statistically significant.

Table 4 Reversion to smoking among switchers, stratified by duration of switching: risk perceptions and sociodemographic characteristics


Switching completely to ENDS has been suggested as a potentially effective harm reduction strategy for smokers who would not otherwise quit smoking cigarettes in the near term [6, 7, 10, 36]. Multiple behavioral theories predict that switching from smoking to ENDS would be promoted when smokers believe that ENDS use is less harmful than smoking, and would be suppressed if smokers believe otherwise [16, 17]. Our analyses confirm this association over multiple waves of the PATH survey. Smokers who believed ENDS were less harmful than smoking were significantly more likely to start using ENDS a year later, and also more likely to stop smoking and switch completely to ENDS. Additionally, the belief that ENDS are less harmful than smoking was associated with maintaining switching, that is, avoiding reversion to smoking among switchers who had been switched for less than a year. Taken together, the findings show that beliefs about the relative harms of ENDS compared to smoking appear to be strongly associated with harm-reduction behaviors, from adoption of ENDS, to switching to ENDS, to maintaining switched status over the first year of switching. While the correlational nature of the data precludes strong causal inferences, the data suggest that risk perceptions may influence harm reduction behaviors.

The results of this analysis are consistent with previous studies of smokers showing how risk perceptions affect smoking and ENDS use. As most smokers acknowledge the risk of cigarette smoking, [37] perceived health benefits are often one of the most important motivations for smokers to use ENDS [18, 38]. Indeed, those who perceive ENDS to be less harmful than cigarettes are more likely to seek information on ENDS, [39] adopt ENDS, [40,41,42] and ultimately switch completely from cigarettes to ENDS [21, 30, 43]. Conversely, misperception that ENDS are at least as harmful as smoking often emerges as an important reason for not trying ENDS, [19] stopping ENDS use even if they have used ENDS, [38] and maintaining dual-use rather than switching to exclusive ENDS use [19].

The present analysis supports these previous findings in a nationally-representative prospective sample, and demonstrates consistent relationships between risk perceptions and multiple stages of behavior change among smokers: in the adoption of ENDS, switching away from smoking with ENDS, and maintaining switched status (at least among recent switchers). Even after completing the full transition from smoking to exclusive ENDS use – which itself was associated with a favorable view of the relative risks of ENDS – believing that ENDS are at least as harmful as cigarettes was associated with switchers reverting back to smoking. That the significant association of risk perceptions with reversion to smoking was seen primarily among recent switchers should not be surprising. Although data on reversion to smoking over time among smokers who switched to ENDS is limited, reversion to smoking (i.e., relapse) after smoking cessation is much more likely in the first year after quitting [23, 24]. Similarly, the pattern of switching may be sufficiently well-established after a year to not be as influenced by risk perceptions.

The misperception that ENDS are at least as harmful as cigarettes has been growing over time [13, 14]. Factors such as misperception of the risks of nicotine, uncertainties about the long-term health effects of ENDS, a confounding of absolute vs. relative risk in scientific publications, media and public perceptions, media coverage, and specific campaigns emphasizing the potential risks of ENDS, often without contextual relative-risk information, have likely contributed to this trend [13, 14, 44]. The shock of EVALI and its initial misattribution to nicotine-containing e-cigarettes in mid-2019, was especially detrimental for the public’s harm perception [45, 46]. Given the relationship between favorable relative-risk perceptions and adoption of harm-reducing behaviors, these findings suggest that risk misperceptions are damaging to public health. Persoskie et al. estimated that 370,000 more dual users would have completely switched away from smoking between PATH Waves 2 and 3, had they perceived ENDS to be less harmful than cigarettes [30]. In the current analysis, most Wave 4 smokers thought ENDS were at least as harmful as smoking (74.3%, or 22.5 million smokers), and only 3.3% of these smokers switched at Wave 5. Had these smokers’ risk perceptions been more favorable, and their switch rates accordingly been higher, the analysis suggests that an additional 1.1 million smokers would have switched to ENDS,Footnote 1 with the attendant reduction in exposure to cigarette-smoke related toxicants, [47, 48] and a potential reduction in smoking-related risk [1, 4,5,6].

Taken together, evidence suggests that correcting smokers’ relative risk perception on ENDS, by providing them with consistent and evidence-based information on relative risks, [49,50,51] may have a significant impact on their harm-reduction behaviors. As the public misperception of ENDS continues to worsen, educational efforts and interventions are more critical than ever. The role of public health agencies is crucial as a credible source of information for public engagement and communication, as they are one of the most trusted sources of information on the health effects of ENDS [52]. Carefully balanced messages that emphasize the relatively lower risks of ENDS for smokers while also noting the absolute risks for nonusers seem necessary [7, 53].

Aside from the relationship between perceived risk and ENDS use, the PATH data show a steep increase in ENDS adoption and switching in Wave 5, which corresponds to 2019. This is consistent with previously-observed sharp increases in ENDS purchases at this time, [54,55,56] primarily driven by 4th generation, cartridge-type ENDS [55,56,57]. These newer generation devices are more satisfying to smokers [58] and are thought to be more effective in inducing complete switching, [59, 60] which may have contributed to the continued decrease in the rate of reversion as well.

Several limitations of these analyses should be taken into account. The observational nature of the PATH study precludes strong causal inferences. The yearly follow-up of the PATH study is not granular enough to capture in detailed behavioral changes between surveys, which makes it challenging to evaluate the precise timing in the changes in behaviors and perception. The interval between surveys varied, but those variations should not be confounded with the variables of interest. The relative risk perception measure was collected in three levels, and the extent of reduced/increased harm was not evaluated. The strongest effect was seen in the contrast between those who perceived ENDS as less harmful than smoking and those who perceived it as more harmful than smoking, though those who perceived the risk of ENDS as equal to that of smoking showed directionally similar effects. One’s risk perception could be affected by various factors, ranging from personal experiences in ENDS use (e.g., physical sensations from use) to publicized changes in major tobacco control policies. The number of switchers included for the reversion analysis was small, which may have resulted in limited power to detect the association between risk perception and reversion among the overall switcher group. No significant interaction effect between risk perception and switching duration in predicting reversion to smoking was found, possibly because the switchers’ association between risk perception and reversion was similar for recent and longer-term switchers. Also, the long-term switchers were very heterogeneous with regard to duration of switching. Longitudinally following a larger sample of ENDS users would be fruitful to address these limitations and may inform the dynamic relationships between risk perception, user experience, and behavioral changes.

Notwithstanding these limitations, this study has significant strengths as well. The analyses were based on large and representative samples of US adult smokers. The analyses considered multiple steps in the process of switching and found directionally consistent effects across them, from the initial adoption of ENDS to complete switching (among current smokers), to reversion from smoking within a year after switching. Factors other than risk perception, such as social influences, also may affect the likelihood of smokers adopting ENDS and switching away from smoking and warrant additional investigation.


In a nationally representative sample of US adult smokers, perceiving ENDS to be less harmful than cigarettes prospectively predicted adopting ENDS, completely switching to ENDS, and maintaining a switched (non-smoking) status over the first year of switching. As misperceptions about the relative risk of ENDS continues to grow, correcting smokers’ misperception to explain that ENDS are less harmful than smoking could reduce smoking and thereby improve population health.

Availability of data and materials

The datasets used for these analyses are from the Population Assessment of Tobacco and Health (PATH) Study; data are available at


  1. Among 22.5 million smokers perceiving equal or more harm of ENDS compared to cigarettes, only 0.7 million smokers (3.3%) reported switching at Wave 5. Had their switching rate been comparable with smokers of more favorable perception (8.0%), the number of switchers in this group would have been as high as 1.8 million, which amounts to 1.1 million additional smokers that could have switched to ENDS.


  1. U.S. Department of Health Human Services. The health consequences of smoking—50 years of progress: a report of the Surgeon General. Atlanta (GA): Department of Health Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.

    Google Scholar 

  2. Cornelius ME, Wang TW, Jamal A, Loretan CG, Neff LJ. Tobacco product use among adults - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(46):1736–42.

    PubMed  PubMed Central  Article  Google Scholar 

  3. U.S. Department of Health and Human Services, Office of the Surgeon General, U.S. Office on Smoking and Health: How tobacco smoke causes disease : the biology and behavioral basis for smoking-attributable disease : a report of the Surgeon General. Rockville, MD: U.S. Dept. of Health and Human Services. London: Public Health Service for sale by the Supt. of Documents, U.S. G.P.O.; 2010.

  4. McNeill A, Brose LS, Calder R, Bauld L, Robson D: Evidence review of e-cigarettes and heated tobacco products 2018. A report commissioned by public health England London. London: Public Health England; 2018, 6.

  5. National Academies of Sciences E, and Medicine,: Public health consequences of e-cigarettes. In: Public Health Consequences of E-Cigarettes. edn. Edited by Eaton DL, Kwan LY, Stratton K. Washington (DC): The National Academies Press; 2018.

  6. Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. London: RCP; 2016.

    Google Scholar 

  7. Abrams DB, Glasser AM, Pearson JL, Villanti AC, Collins LK, Niaura RS. Harm minimization and tobacco control: reframing societal views of nicotine use to rapidly save lives. Annu Rev Public Health. 2018;39:193–213.

    PubMed  PubMed Central  Article  Google Scholar 

  8. FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death []

  9. Glasser AM, Collins L, Pearson JL, Abudayyeh H, Niaura RS, Abrams DB, Villanti AC. Overview of electronic nicotine delivery systems: a systematic review. Am J Prev Med. 2017;52(2):e33–66.

    PubMed  Article  Google Scholar 

  10. Nutt DJ, Phillips LD, Balfour D, Curran HV, Dockrell M, Foulds J, Fagerstrom K, Letlape K, Milton A, Polosa R. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res. 2014;20(5):218–25.

    PubMed  Article  Google Scholar 

  11. Vaping and quitting smoking []

  12. Vaping vs. Smoking []

  13. Huang J, Feng B, Weaver SR, Pechacek TF, Slovic P, Eriksen MP. Changing perceptions of harm of e-cigarette vs cigarette use among adults in 2 US national surveys from 2012 to 2017. JAMA Netw Open. 2019;2(3):e191047.

    PubMed  PubMed Central  Article  Google Scholar 

  14. Malt L, Verron T, Cahours X, Guo M, Weaver S, Walele T, O’Connell G. Perception of the relative harm of electronic cigarettes compared to cigarettes amongst US adults from 2013 to 2016: analysis of the Population Assessment of Tobacco and Health (PATH) study data. Harm Reduct J. 2020;17(1):65.

    PubMed  PubMed Central  Article  Google Scholar 

  15. Abrams DB, Glasser AM, Villanti AC, Pearson JL, Rose S, Niaura RS. Managing nicotine without smoke to save lives now: Evidence for harm minimization. Prev Med. 2018;117:88–97.

    PubMed  PubMed Central  Article  Google Scholar 

  16. Rosenstock IM. The health belief model and preventive health behavior. Health Educ Monogr. 1974;2(4):354–86.

    Article  Google Scholar 

  17. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179–211.

    Article  Google Scholar 

  18. Soule EK, Plunk AD, Harrell PT, Hayes RB, Edwards KC. Longitudinal analysis of associations between reasons for electronic cigarette use and change in smoking status among adults in the population assessment of tobacco and health study. Nicotine Tob Res. 2020;22(5):663–71.

    PubMed  Article  Google Scholar 

  19. McKeganey N, Dickson T. Why don’t more smokers switch to using E-Cigarettes: the views of confirmed smokers. Int J Environ Res Public Health. 2017;14(6):647.

    PubMed Central  Article  Google Scholar 

  20. Majeed BA, Weaver SR, Gregory KR, Whitney CF, Slovic P, Pechacek TF, Eriksen MP. Changing perceptions of harm of E-cigarettes among U.S. adults, 2012–2015. Am J Prev Med. 2017;52(3):331–8.

    PubMed  Article  Google Scholar 

  21. Evans AT, Henderson KC, Geier A, Weaver SR, Spears CA, Ashley DL, Fritz M, John L, Pechacek TF. What Motivates Smokers to Switch to ENDS? A Qualitative Study of Perceptions and Use. Int J Environ Res Public Health. 2020;17(23):8865.

    PubMed Central  Article  Google Scholar 

  22. Technical Project Lead Review of PMTAs []

  23. Hughes JR, Peters EN, Naud S. Relapse to smoking after 1 year of abstinence: a meta-analysis. Addict Behav. 2008;33(12):1516–20.

    PubMed  PubMed Central  Article  Google Scholar 

  24. Jackson SE, McGowan JA, Ubhi HK, Proudfoot H, Shahab L, Brown J, West R. Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation. Addiction. 2019;114(5):787–97.

    PubMed  PubMed Central  Article  Google Scholar 

  25. Brose LS, Bowen J, McNeill A, Partos TR. Associations between vaping and relapse to smoking: preliminary findings from a longitudinal survey in the UK. Harm Reduct J. 2019;16(1):76.

    PubMed  PubMed Central  Article  Google Scholar 

  26. Dai H, Leventhal AM. Association of electronic cigarette vaping and subsequent smoking relapse among former smokers. Drug Alcohol Depend. 2019;199:10–7.

    PubMed  PubMed Central  Article  Google Scholar 

  27. Hyland A, Ambrose BK, Conway KP, Borek N, Lambert E, Carusi C, Taylor K, Crosse S, Fong GT, Cummings KM, et al. Design and methods of the Population Assessment of Tobacco and Health (PATH) Study. Tob Control. 2017;26(4):371–8.

    PubMed  Article  Google Scholar 

  28. National Cancer Institute: 2018–19 Summary Table Technical Notes. 2020.

  29. Centers for Disease Control and Prevention: National Health Interview Survey. Glossary. 2017.

  30. Persoskie A, O’Brien EK, Poonai K. Perceived relative harm of using e-cigarettes predicts future product switching among US adult cigarette and e-cigarette dual users. Addiction. 2019;114(12):2197–205.

    PubMed  Article  Google Scholar 

  31. Fong GT, Elton-Marshall T, Driezen P, Kaufman AR, Cummings KM, Choi K, Kwan J, Koblitz A, Hyland A, Bansal-Travers M, et al. U.S. adult perceptions of the harmfulness of tobacco products: descriptive findings from the 2013–14 baseline wave 1 of the path study. Addict Behav. 2019;91:180–7.

    PubMed  Article  Google Scholar 

  32. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerström test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–27.

    CAS  PubMed  Article  Google Scholar 

  33. U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Food and Drug Administration, Center for Tobacco Products: Population Assessment of Tobacco and Health (PATH) Study [United States] Public Use-files: User Guide. Bethesda, Maryland: Inter-university Consortium for Political and Social Research; 2018.

  34. Kasza KA, Edwards KC, Tang Z, Stanton CA, Sharma E, Halenar MJ, Taylor KA, Donaldson E, Hull LC, Day H, et al. Correlates of tobacco product initiation among youth and adults in the USA: findings from the PATH Study Waves 1–3 (2013–2016). Tob Control. 2020;29(Suppl 3):s191–202.

    PubMed  Article  Google Scholar 

  35. Pan W. Akaike’s information criterion in generalized estimating equations. Biometrics. 2001;57(1):120–5.

    CAS  PubMed  Article  Google Scholar 

  36. McNeill A, Brose L, Calder R, Simonavicius E, Robson D. Vaping in England: An evidence update including vaping for smoking cessation, February 2021. London: Public Health England; 2021. p. 1–247.

    Google Scholar 

  37. Sutton S. Social-psychological approaches to understanding addictive behaviours: attitude-behaviour and decision-making models. Br J Addict. 1987;82(4):355–70.

    CAS  PubMed  Article  Google Scholar 

  38. Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res. 2015;17(2):127–33.

    PubMed  Article  Google Scholar 

  39. Iles IA, Gillman AS, Klein WMP, Ferrer RA, Kaufman A: Associations between absolute and relative electronic cigarette harm perceptions and information-seeking behaviours among US adult current, former and never smokers. Drug Alcohol Rev. 2021;41(2):356–64.

  40. Brose LS, Brown J, Hitchman SC, McNeill A. Perceived relative harm of electronic cigarettes over time and impact on subsequent use. A survey with 1-year and 2-year follow-ups. Drug Alcohol Depend. 2015;157:106–11.

    PubMed  PubMed Central  Article  Google Scholar 

  41. Elton-Marshall T, Driezen P, Fong GT, Cummings KM, Persoskie A, Wackowski O, Choi K, Kaufman A, Strong D, Gravely S, et al. Adult perceptions of the relative harm of tobacco products and subsequent tobacco product use: Longitudinal findings from waves 1 and 2 of the population assessment of tobacco and health (PATH) study. Addict Behav. 2020;106:106337.

    PubMed  PubMed Central  Article  Google Scholar 

  42. Wackowski OA, Delnevo CD. Young adults’ risk perceptions of various tobacco products relative to cigarettes: results from the national young adult health survey. Health Educ Behav. 2016;43(3):328–36.

    PubMed  Article  Google Scholar 

  43. Farsalinos KE, Romagna G, Voudris V. Factors associated with dual use of tobacco and electronic cigarettes: A case control study. Int J Drug Policy. 2015;26(6):595–600.

    PubMed  Article  Google Scholar 

  44. Wilson S, Partos T, McNeill A, Brose LS. Harm perceptions of e-cigarettes and other nicotine products in a UK sample. Addiction. 2019;114(5):879–88.

    PubMed  PubMed Central  Article  Google Scholar 

  45. Dave D, Dench D, Kenkel D, Mathios A, Wang H. News that takes your breath away: risk perceptions during an outbreak of vaping-related lung injuries. J Risk Uncertain. 2020;60(3):281–307.

    PubMed  PubMed Central  Article  Google Scholar 

  46. Wackowski OA, Gratale SK, Jeong M, Delnevo CD, Steinberg MB, O'Connor RJ. Over 1 year later: smokers’ EVALI awareness, knowledge and perceived impact on e-cigarette interest. Tobacco Control. 2022:tobaccocontrol-2021–057190.

  47. Cohen G, Goldenson NI, Bailey PC, Chan S, Shiffman S.  Changes in biomarkers of cigarette smoke exposure after 6 days of switching exclusively or partially to use of the JUUL system with two nicotine concentrations: a randomized controlled confinement study in adult smokers. Nicotine Tob Res 2021;23(12):2153–61.

  48. Pulvers K, Nollen NL, Rice M, Schmid CH, Qu K, Benowitz NL, Ahluwalia JS. Effect of pod e-cigarettes vs cigarettes on carcinogen exposure among African American and latinx smokers: a randomized clinical trial. JAMA Netw Open. 2020;3(11):e2026324.

    PubMed  PubMed Central  Article  Google Scholar 

  49. Yang B, Owusu D, Popova L. Testing messages about comparative risk of electronic cigarettes and combusted cigarettes. Tob Control. 2019;28(4):440–8.

    PubMed  Article  Google Scholar 

  50. Pepper JK, Byron MJ, Ribisl KM, Brewer NT. How hearing about harmful chemicals affects smokers’ interest in dual use of cigarettes and e-cigarettes. Prev Med. 2017;96:144–8.

    PubMed  Article  Google Scholar 

  51. Erku DA, Bauld L, Dawkins L, Gartner CE, Steadman KJ, Noar SM, Shrestha S, Morphett K. Does the content and source credibility of health and risk messages related to nicotine vaping products have an impact on harm perception and behavioural intentions? A systematic review. Addiction. 2021;116(12):3290–303.

    PubMed  Article  Google Scholar 

  52. Owusu D, Weaver SR, Yang B, Ashley DL, Popova L. Trends in trust in the sources of health information on E-cigarettes among US adults, 2015–2017. Am J Public Health. 2019;109(1):145–7.

    PubMed  PubMed Central  Article  Google Scholar 

  53. Britton J, Bogdanovica I, McNeill A, Bauld L. Commentary on WHO Report on electronic nicotine delivery systems and electronic non-nicotine delivery systems. UK Centre for Tobacco & Alcohol Studies. 2016.

  54. Liber A, Cahn Z, Larsen A, Drope J. Flavored E-cigarette sales in the United States under self-regulation from January 2015 through October 2019. Am J Public Health. 2020;110(6):785–7.

    PubMed  PubMed Central  Article  Google Scholar 

  55. Ali FRM, Diaz MC, Vallone D, Tynan MA, Cordova J, Seaman EL, Trivers KF, Schillo BA, Talley B, King BA. E-cigarette unit sales, by product and flavor type - United States, 2014–2020. MMWR Morb Mortal Wkly Rep. 2020;69(37):1313–8.

    PubMed  PubMed Central  Article  Google Scholar 

  56. Euromonitor International. Smokeless Tobacco, E-Vapour Products and Heated Tobacco in the US. London, UK; 2022.

  57. Centers for Disease Control and Prevention: E-Cigarette, or vaping, products visual dictionary. Atlanta, GA. 2020.

  58. Hajek P, Pittaccio K, Pesola F, Myers Smith K, Phillips-Waller A, Przulj D. Nicotine delivery and users’ reactions to Juul compared with cigarettes and other e-cigarette products. Addiction. 2020;115(6):1141–8.

    PubMed  PubMed Central  Article  Google Scholar 

  59. Hajek P, Przulj D, Phillips A, Anderson R, McRobbie H. Nicotine delivery to users from cigarettes and from different types of e-cigarettes. Psychopharmacology. 2017;234(5):773–9.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  60. Caponnetto P, DiPiazza J, Kim J, Maglia M, Polosa R. A single-arm, open-label, pilot, and feasibility study of a high nicotine strength E-cigarette intervention for smoking cessation or reduction for people with schizophrenia spectrum disorders who smoke cigarettes. Nicotine Tob Res. 2021;23(7):1113–22.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

Download references


Not applicable.


Funding for this study was provided by Juul Labs, Inc. Juul Labs, Inc. had an opportunity to comment on the initial conceptualization and near-final draft of the study, but did not have any role in data management, analysis, interpretation of data, manuscript preparation, or decision to submit the manuscript for publication.

Author information

Authors and Affiliations



SK and SS conceptualized and designed the study. SK and MAS performed the statistical analyses. SK and SS drafted and edited the manuscript. All authors have read and approved the final manuscript before submission.

Authors’ information

Not applicable.

Corresponding author

Correspondence to Sooyong Kim.

Ethics declarations

Ethics approval and consent to participate

This is a secondary analysis of publicly available PATH data. The PATH study was conducted by Westat, Inc. and approved by Westat’s institutional review board (Project Number 8954, FWA 00005551). All analyses were performed in accordance with the relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

SK, SS, and MAS provide consulting services on tobacco harm reduction on an exclusive basis to Juul Labs, Inc. through PinneyAssociates, Inc. SS holds a patent for a novel nicotine medication that has not been developed or commercialized.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

Supplementary Table 1. Associations between three-level risk perception and adoption/switching: results from multivariable GEE modeling. Supplement Table 2. Smoking profile and history of participants. Supplement Table 3. Sociodemographic characteristics of the sample by risk perception and the proportion of those reporting the outcome in the following wave. Supplement Table 4. Sociodemographic characteristics of switchers by switching duration and the proportion of those reporting reversion in the following wave.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kim, S., Shiffman, S. & Sembower, M.A. US adult smokers’ perceived relative risk on ENDS and its effects on their transitions between cigarettes and ENDS. BMC Public Health 22, 1771 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Electronic cigarette
  • Electronic nicotine delivery system
  • Tobacco
  • Smoking
  • Cigarette
  • Risk perception
  • Harm reduction